NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 143 filers reported holding NEOGENOMICS INC in Q4 2016. The put-call ratio across all filers is 0.26 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $61,824,000 | -76.6% | 5,088,357 | -34.2% | 0.08% | -73.8% |
Q4 2021 | $263,828,000 | -21.1% | 7,732,355 | +11.6% | 0.31% | -23.3% |
Q3 2021 | $334,353,000 | +52.8% | 6,931,041 | +43.1% | 0.41% | +56.3% |
Q2 2021 | $218,821,000 | -6.5% | 4,844,379 | -0.2% | 0.26% | -11.8% |
Q1 2021 | $234,028,000 | -8.1% | 4,852,328 | +2.6% | 0.30% | -4.5% |
Q4 2020 | $254,528,000 | +49.6% | 4,727,487 | +2.5% | 0.31% | +29.2% |
Q3 2020 | $170,084,000 | +13.9% | 4,610,563 | -4.4% | 0.24% | +0.4% |
Q2 2020 | $149,333,000 | +63.5% | 4,820,298 | +45.7% | 0.24% | +21.9% |
Q1 2020 | $91,352,000 | +6.5% | 3,308,666 | +12.8% | 0.20% | +30.7% |
Q4 2019 | $85,764,000 | +101.4% | 2,932,090 | +31.7% | 0.15% | +85.2% |
Q3 2019 | $42,581,000 | +17.4% | 2,227,053 | +34.8% | 0.08% | +20.9% |
Q2 2019 | $36,257,000 | +19.1% | 1,652,562 | +11.1% | 0.07% | +11.7% |
Q1 2019 | $30,439,000 | +63.0% | 1,487,720 | +0.5% | 0.06% | +42.9% |
Q4 2018 | $18,669,000 | -22.8% | 1,480,487 | -6.0% | 0.04% | -8.7% |
Q3 2018 | $24,183,000 | -15.2% | 1,575,423 | -27.6% | 0.05% | -19.3% |
Q2 2018 | $28,515,000 | +61.7% | 2,175,072 | +0.7% | 0.06% | +58.3% |
Q1 2018 | $17,630,000 | -12.9% | 2,160,489 | -5.4% | 0.04% | -5.3% |
Q4 2017 | $20,232,000 | -22.1% | 2,283,514 | -2.2% | 0.04% | -20.8% |
Q3 2017 | $25,980,000 | +22.7% | 2,334,203 | -1.2% | 0.05% | +20.0% |
Q2 2017 | $21,175,000 | +9.4% | 2,363,238 | -3.7% | 0.04% | +5.3% |
Q1 2017 | $19,353,000 | -12.3% | 2,452,840 | -4.7% | 0.04% | -17.4% |
Q4 2016 | $22,064,000 | -4.7% | 2,574,507 | -8.6% | 0.05% | 0.0% |
Q3 2016 | $23,145,000 | +0.7% | 2,815,688 | -1.5% | 0.05% | -6.1% |
Q2 2016 | $22,987,000 | +15.1% | 2,859,065 | -3.5% | 0.05% | +16.7% |
Q1 2016 | $19,970,000 | -16.0% | 2,962,958 | -1.9% | 0.04% | -10.6% |
Q4 2015 | $23,781,000 | +33.5% | 3,021,726 | -2.8% | 0.05% | +30.6% |
Q3 2015 | $17,815,000 | +10.3% | 3,109,079 | +4.2% | 0.04% | +20.0% |
Q2 2015 | $16,149,000 | +1.0% | 2,984,950 | -12.8% | 0.03% | +3.4% |
Q1 2015 | $15,985,000 | +15.8% | 3,422,908 | +3.4% | 0.03% | +20.8% |
Q4 2014 | $13,805,000 | +38.4% | 3,310,659 | +73.0% | 0.02% | +33.3% |
Q3 2014 | $9,973,000 | – | 1,914,120 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kopp Family Office, LLC | 2,023,355 | $91,395,000 | 37.83% |
Blue Water Life Science Advisors, LP | 702,222 | $31,719,000 | 11.94% |
Burrage Capital Management LLC | 147,921 | $6,682,000 | 6.70% |
PERKINS CAPITAL MANAGEMENT INC | 158,300 | $7,150,000 | 4.06% |
First Light Asset Management, LLC | 1,148,945 | $51,898,000 | 3.11% |
Soleus Capital Management, L.P. | 352,007 | $15,900,000 | 2.44% |
Ranger Investment Management | 832,286 | $37,594,000 | 1.96% |
Avidity Partners Management LP | 1,367,000 | $61,747,000 | 1.67% |
Bullseye Asset Management LLC | 108,672 | $4,909,000 | 1.65% |
Tygh Capital Management, Inc. | 255,541 | $11,543,000 | 1.57% |